The permanent Botox smile may be on the way out. The FDA is expected to approve Evolence for use in the US this spring. Evolence lasts longer and studies have shown that the effects last longer and are "softer" than Botox. Already in use in Europe, Evolence treatments can last up to 12 months.
Implications - There is a growing demand for appearance-enhancing products that don't require surgery, but to date, most effects have been short-lived, which has caused some budget-conscious consumers to reconsider. The ability of a smile-enhancing injection to last longer than before may be the extra push some hesitant consumers need when weighing the costs and benefits of physical beauty enhancement.
Key Themes Behind This Trend
- Long-lasting Anti-wrinkle Treatments
- Evolence offers a new option for consumers who seek longer-lasting alternatives to traditional anti-wrinkle treatments.
- Soft Anti-wrinkle Treatments
- Evolence offers a less harsh alternative to traditional anti-wrinkle treatments which may attract more consumers looking for a more natural look.
- Non-surgical Beauty Enhancements
- Evolence offers an alternative to surgical beauty enhancements by providing consumers with longer-lasting injection treatments.
Where This Applies
- Cosmetic Industry
- Evolence will disrupt the anti-wrinkle treatment market by providing a new product that offers longer-lasting and softer results.
- Pharmaceutical Industry
- Evolence will provide pharmaceutical companies with a new direction in developing long-lasting and soft anti-wrinkle treatments.
- Medical Equipment Industry
- There will be a need for new medical equipment for delivering Evolence treatments, providing opportunities for innovation in the medical equipment industry.
